seed
Stage
1
Investors
About
Karma Biotechnologies engineers cytokine-based therapeutics aimed at improving the effectiveness and safety of immunotherapies for cancer and autoimmune diseases.
Explore Karma Biotechnologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.